Ashley Orillion, PhD
Principle Scientist, AAb PAS Biomarker Platform Development Lead
Janssen Immunology
Translational Sciences Study Lead for Ph2/3 clinical trials going through study start-up, enrollment, and end of study biomarker analyses within the Rheumatology & Maternal Fetal Immunology Disease Areas.
Translational Sciences Program Lead for an asset in Discovery working towards NME and FIH goals.
AutoAntibody Platform Evaluation Lead for our AutoAntibody Pathway Area Stronghold.
https://www.linkedin.com/in/ashleyorillion/
Speaking In
-
06-Jun-2024